en.wikipedia.org/wiki/Abdullahi_v._Pfizer,_Inc.

The Kano trovafloxacin trial litigation arose out of a clinical trial conducted by the .... ever been treated with Trovan, and then only after all other antibiotics failed.

casetext.com/case/abdullahi-v-pfizer-inc

Summary of this case from Kiobel v. .... Pfizer International, Inc., [2001] Suit No. ..... M. Cheriff Bassiouni et al., An Appraisal of Human Experimentation in ...

law.justia.com/cases/federal/appellate-courts/ca7/17-2056/17-2056-2018-01-19.html

Jan 19, 2018 ... In Wyeth v. Levine, the Supreme Court held that claims against a manufacturer of a brand-name prescription drug for failure to warn adequately ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC5645434

Jul 27, 2017 ... Palbociclib (IBRANCE®; Pfizer Inc, New York, NY, USA) is a new oral cyclin- dependent kinase ... All references used in two previous NMAs by Generali et al. .... Model fit statistics, Residual deviance = 25.08 vs. ..... Migliaccio I, Malorni L, Hart CD, Guarducci C, Di Leo A. Endocrine therapy considerations in ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC2952544

Jul 29, 2010 ... For all markers, the pan-cytokeratin signal was used to create an epithelial “mask ” to distinguish .... to those tumors with squamous cell histology (Figure 3B (SQ), median AQUA scores 5,885 vs. ..... Disclosures: This research was supported by Pfizer Inc. ... Gustavson MD, Bourke-Martin B, Reilly DM, et al.

www.plainsite.org/judges/california-northern-district-court/charles-r-breyer

7/13/2016 · 3:16-cv-03922 · Schaaf-Richards v. Volkswagen Group of America, Inc. et al ...... 3:07-cv-06497-CRB · Abad v. Bronson & Migliaccio. LLP et al ...

www.sciencedirect.com/science/article/pii/S0149291813009430

Of these, 5.8% switched, 51.3% permanently discontinued all anticholinergic agents, and .... Detrol, Detrol LA and Toviaz (Pfizer Inc., New York, New York). ‡ .... switches are almost one third the rate observed by D'Souza et al (5.8% vs 13 %). ... Ms. Migliaccio-Walle led the manuscript preparation, provided oversight and ...

mcr.aacrjournals.org/content/molcanres/14/5/470.full.pdf

Mar 10, 2016 ... postmenopausal patients with all stages of ER ю breast cancer (1). ...... Luca Malorni, Mario Giuliano, Ilenia Migliaccio, et al. Resistance.

bmcmedicine.biomedcentral.com/articles/10.1186/s12916-015-0280-0

Mar 5, 2015 ... Ilenia Migliaccio,; Luca Malorni,; Christopher D Hart,; Cristina Guarducci and; Angelo Di LeoEmail ... Migliaccio et al.; licensee BioMed Central.